Iron Deficiency Anemia Market Growth, Trends & Forecast 2025 | Top key players - AbbVie., Shield Therapeutics plc, GSK plc.

The Global Iron Deficiency Anemia Market reached US$ 4.39 billion in 2024 and is expected to reach US$ 7.33 billion by 2032, growing at a CAGR of 6.8 % during the forecast period 2025-2032.

Iron Deficiency Anemia Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

Iron Deficiency Anemia (IDA) is a common condition where the body lacks sufficient iron to produce healthy red blood cells. This leads to symptoms like fatigue, weakness, and shortness of breath. The market for IDA focuses on treatments, including iron supplements and intravenous iron therapy, aimed at improving iron levels and alleviating symptoms, driving growth in the healthcare sector.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/iron-deficiency-anemia-market?sz

Market opportunities and Growth Drivers:

Increasing Prevalence of Iron Deficiency Anemia

The rising prevalence of iron deficiency anemia (IDA) is a major factor driving the growth of the global IDA market. One of the key contributors to this condition is insufficient dietary iron intake, which remains a widespread issue. Many populations, especially in developing regions, lack access to iron-rich foods, leading to a higher incidence of anemia. In addition, poor dietary habits that don't prioritize iron-rich sources are exacerbating the problem.

According to a research study published by the National Center for Biotechnology Information (NCBI) in January 2022, the World Health Organization (WHO) has identified IDA as the most common nutritional deficiency worldwide, affecting about 30% of the global population. While IDA is particularly prevalent among children and women, adult men are also at risk, especially depending on factors like socioeconomic status and overall health.

Iron Deficiency Anemia Market Recent Development:

In October 2024, P&G Health India, in collaboration with the Federation of Obstetric and Gynaecological Societies of India (FOGSI), launched the '12 Ka Naara' campaign to address the widespread issue of iron deficiency anemia (IDA) in India. This initiative is crucial, as IDA affects around 57% of Indian women, according to data from the National Family Health Survey (NFHS-5). The campaign aims to raise awareness about the condition, which often goes unnoticed until it reaches severe stages. The effort focuses on educating women about the importance of regular iron intake and promoting proactive health management.

List of the Key Players in the Iron Deficiency Anemia Market:

Daiichi Sankyo, Inc., Covis Pharma GmbH., Akebia Therapeutics, Inc., PHARMACOSMOS A/S, AbbVie., Shield Therapeutics plc, GSK plc, Rockwell Medical, Inc., Kye Pharmaceuticals, Inc., and Cadila Pharmaceuticals among others.

Research Process:

Both primary and secondary data sources have been used in the global Iron Deficiency Anemia Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/iron-deficiency-anemia-market

Segment Covered in the Iron Deficiency Anemia Market:

By Therapy Type: Oral Iron Therapy (Ferrous Sulfate, Ferrous Gluconate, Ferrous Fumarate, Polysaccharide Iron Complex), Parenteral Iron Therapy (Ferric Carboxymaltose, Ferumoxytol, Iron Sucrose, Iron Dextran), Red Blood Cell Transfusion, Others.

By Age Group: Adults, Pediatric, Geriatric.

By end-user: Hospitals, Specialty Clinics, Homecare Settings.

Regional Analysis for Iron Deficiency Anemia Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the Iron Deficiency Anemia Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Iron Deficiency Anemia market?

➠ Who are the top manufacturers in the global Iron Deficiency Anemia industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Iron Deficiency Anemia market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Iron Deficiency Anemia market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Iron Deficiency Anemia industry landscape?

Browse More Reports: https://www.datamintelligence.com/research-report/iron-deficiency-anemia-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.